Search Results

Danaher Corporation (NYSE:DHR) (“Danaher”) announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) (“Abcam”).

Abcam plc, a global leader in the supply of life science research tools, held an Extraordinary General Meeting of its shareholders that was convened following a requisition notice from Dr. Jonathan Milner dated May 30, 2023.

Abcam plc, a global leader in the supply of life science research tools, provides the following updates.

Abcam plc, a global leader in the supply of life science research tools, announces its interim results for the six-month period ended 30 June 2023.

Abcam plc, a global leader in the supply of life science research tools, provides the following preliminary trading update for the quarter ending 31 March 2023.

Abcam plc, a global leader in the supply of life science research tools, notes the Form 13D filed by founder and former director Dr Jonathan Milner and related press reports.

Abcam today announced the appointment of Markus Lusser as President.

Abcam plc, a global leader in the supply of life science research tools, notes that it has received a notice from Dr. Jonathan Milner seeking to require the Board of Directors to convene an Extraordinary General Meeting.

Abcam plc, a global leader in the supply of life science research tools, announces the voting results from the Annual General Meeting.

Abcam plc, a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation, announced that its shareholders have approved the proposal for Danaher to acquire all of the outstanding shares of Abcam for $24.00 per share in cash.